The Korean journal of internal medicine

The Korean Association of Internal Medicine (대한내과학회)
권호 표지
DOI QR코드

DOI QR Code

Adipokines, insulin-like growth factor binding protein-3 levels, and insulin sensitivity in women with polycystic ovary syndrome

  • Lee, Hyejin (Department of Internal Medicine, Ewha Womans University School of Medicine) ;
  • Oh, Jee-Young (Department of Internal Medicine, Ewha Womans University School of Medicine) ;
  • Sung, Yeon-Ah (Department of Internal Medicine, Ewha Womans University School of Medicine)
  • Published : 2013.07.01
⟨ Previous Next ⟩

Abstract

Background/Aims: Many women with polycystic ovary syndrome (PCOS) exhibit insulin resistance. Adipose tissue plays an important role in insulin resistance, and adipokines including tumor necrosis factor (TNF)-${\alpha}$ and adiponectin are altered in PCOS. Insulin-like growth factor binding protein-3 (IGFBP-3), alone or in conjunction with other adipokines, is also associated with insulin resistance. We evaluated the effects of TNF-${\alpha}$, adiponectin, and IGFBP-3 on insulin sensitivity and the relationships among these proteins in women with PCOS. Methods: We recruited 40 women with PCOS and 40 age- and body mass index (BMI)-matched regular cycling women (controls). The women were divided into obese ($BMI{\geq}25kg/m^2$) and nonobese (BMI < $25kg/m^2$) groups. Anthropometric measurements were performed, and serum levels of TNF-${\alpha}$, adiponectin, and IGFBP-3 were determined. Insulin sensitivity was estimated using the metabolic clearance rate (MCR) of glucose calculated from the oral glucose tolerance test. Results: Serum levels of TNF-${\alpha}$ and IGFBP-3 did not differ between the PCOS and control groups, but adiponectin levels in the PCOS group were lower than those in control women in the nonobese group (p < 0.05). TNF-${\alpha}$, adiponectin, and IGFBP-3 levels were not correlated with each other in women with PCOS, but a significant positive correlation was observed between adiponectin levels and MCR (p < 0.05). Multiple regression analysis revealed that adiponectin levels were significantly associated with insulin sensitivity (p < 0.05) in women with PCOS. Conclusions: IGFBP-3 and TNF-${\alpha}$ levels were not associated with insulin sensitivity, but adiponectin levels were related to insulin sensitivity in women with PCOS.

Keywords

References

  1. Dunaif A, Thomas A. Current concepts in the polycystic ovary syndrome. Annu Rev Med 2001;52:401-419. https://doi.org/10.1146/annurev.med.52.1.401
  2. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 1997;18:774-800.
  3. Oh JY, Lee JA, Lee H, Sung YA, Chung H. Serum C-reactive protein levels in normal-weight polycystic ovary syndrome. Korean J Intern Med 2009;24:350-355. https://doi.org/10.3904/kjim.2009.24.4.350
  4. Ruan H, Lodish HF. Insulin resistance in adipose tissue: direct and indirect effects of tumor necrosis factor-alpha. Cytokine Growth Factor Rev 2003;14:447-455. https://doi.org/10.1016/S1359-6101(03)00052-2
  5. Tarkun I, Cetinarslan B, Turemen E, Canturk Z, Biyikli M. Association between circulating tumor necrosis factor-alpha, interleukin-6, and insulin resistance in normal-weight women with polycystic ovary syndrome. Metab Syndr Relat Disord 2006;4:122-128. https://doi.org/10.1089/met.2006.4.122
  6. Toulis KA, Goulis DG, Farmakiotis D, et al. Adiponectin levels in women with polycystic ovary syndrome: a systematic review and a meta-analysis. Hum Reprod Update 2009;15:297-307. https://doi.org/10.1093/humupd/dmp006
  7. Weyer C, Funahashi T, Tanaka S, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001;86:1930-1935. https://doi.org/10.1210/jcem.86.5.7463
  8. Firth SM, Baxter RC. Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev 2002;23:824-854. https://doi.org/10.1210/er.2001-0033
  9. Murphy LJ. The role of the insulin-like growth factors and their binding proteins in glucose homeostasis. Exp Diabesity Res 2003;4:213-224. https://doi.org/10.1155/EDR.2003.213
  10. Liu B, Lee HY, Weinzimer SA, et al. Direct functional interactions between insulin-like growth factor-binding protein-3 and retinoid X receptor-alpha regulate transcriptional signaling and apoptosis. J Biol Chem 2000;275:33607-33613. https://doi.org/10.1074/jbc.M002547200
  11. Toth B, Hornung D, Scholz C, Djalali S, Friese K, Jeschke U. Peroxisome proliferator-activated receptors: new players in the field of reproduction. Am J Reprod Immunol 2007;58:289-310. https://doi.org/10.1111/j.1600-0897.2007.00514.x
  12. Kim HS, Ali O, Shim M, et al. Insulin-like growth factor binding protein-3 induces insulin resistance in adipocytes in vitro and in rats in vivo. Pediatr Res 2007;61:159-164. https://doi.org/10.1203/pdr.0b013e31802d8a30
  13. Besset V, Le Magueresse-Battistoni B, Collette J, Benahmed M. Tumor necrosis factor alpha stimulates insulin-like growth factor binding protein 3 expression in cultured porcine Sertoli cells. Endocrinology 1996;137:296-303. https://doi.org/10.1210/endo.137.1.8536626
  14. Rozen F, Zhang J, Pollak M. Antiproliferative action of tumor necrosis factor-alpha on MCF-7 breastcancer cells is associated with increased insulin-like growth factor binding protein-3 accumulation. Int J Oncol 1998;13:865-869.
  15. Rajah R, Lee KW, Cohen P. Insulin-like growth factor binding protein-3 mediates tumor necrosis factoralpha-induced apoptosis: role of Bcl-2 phosphorylation. Cell Growth Differ 2002;13:163-171.
  16. Fauser BC, Tarlatzis BC, Rebar RW, et al. Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril 2012;97:28-38. https://doi.org/10.1016/j.fertnstert.2011.09.024
  17. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999;84:3666-3672. https://doi.org/10.1210/jcem.84.10.6079
  18. Stumvoll M, Mitrakou A, Pimenta W, et al. Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 2000;23:295-301. https://doi.org/10.2337/diacare.23.3.295
  19. World Health Organization, Regional Off ice for the Western Pacific; International Association for the Study of Obesity; International Obesity Task Force. The Asia-Pacific Perspective: Redefining Obesity and Its Treatment. Melbourne: Health Communications Australia, 2000.
  20. Bremer AA, Miller WL. The serine phosphorylation hypothesis of polycystic ovary syndrome: a unifying mechanism for hyperandrogenemia and insulin resistance. Fertil Steril 2008;89:1039-1048. https://doi.org/10.1016/j.fertnstert.2008.02.091
  21. Villa J, Pratley RE. Adipose tissue dysfunction in polycystic ovary syndrome. Curr Diab Rep 2011;11:179-184. https://doi.org/10.1007/s11892-011-0189-8
  22. Festa A, D'Agostino R Jr, Howard G, Mykkanen L, Tracy RP, Haffner SM. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2000;102:42-47. https://doi.org/10.1161/01.CIR.102.1.42
  23. Wickham EP 3rd, Cheang KI, Clore JN, Baillargeon JP, Nestler JE. Total and high-molecular weight adiponectin in women with the polycystic ovary syndrome. Metabolism 2011;60:366-372. https://doi.org/10.1016/j.metabol.2010.02.019
  24. Escobar-Morreale HF, Luque-Ramirez M, Gonzalez F. Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis. Fertil Steril 2011;95:1048-1058. https://doi.org/10.1016/j.fertnstert.2010.11.036
  25. Boney CM, Moats-Staats BM, Stiles AD, D'Ercole AJ. Expression of insulin-like growth factor-I (IGF-I) and IGF-binding proteins during adipogenesis. Endocrinology 1994;135:1863-1868. https://doi.org/10.1210/endo.135.5.7525256
  26. Wabitsch M, Heinze E, Debatin KM, Blum WF. IGF-Iand IGFBP-3-expression in cultured human preadipocytes and adipocytes. Horm Metab Res 2000;32:555-559. https://doi.org/10.1055/s-2007-978685
  27. Chan SS, Twigg SM, Firth SM, Baxter RC. Insulin-like growth factor binding protein-3 leads to insulin resistance in adipocytes. J Clin Endocrinol Metab 2005;90:6588-6595. https://doi.org/10.1210/jc.2005-0595
  28. Ricort JM, Binoux M. Insulin-like growth factor-binding protein-3 activates a phosphotyrosine phosphatase: effects on the insulin-like growth factor signaling pathway. J Biol Chem 2002;277:19448-19454. https://doi.org/10.1074/jbc.M200439200

Cited by

  1. Low circulating adiponectin levels in women with polycystic ovary syndrome: an updated meta-analysis vol.35, pp.5, 2014, https://doi.org/10.1007/s13277-013-1595-0
  2. Insulin resistance and its relationship with high molecular weight adiponectin in adolescents with polycystic ovary syndrome and a maternal history of polycystic ovary syndrome vol.102, pp.3, 2013, https://doi.org/10.1016/j.fertnstert.2014.05.032
  3. Comparison of Various Anthropometric Indices as Risk Factors for Hearing Impairment in Asian Women vol.10, pp.11, 2013, https://doi.org/10.1371/journal.pone.0143119
  4. High Serum Tumor Necrosis Factor-Alpha Levels in Women with Polycystic Ovary Syndrome: A Meta-Analysis vol.11, pp.10, 2013, https://doi.org/10.1371/journal.pone.0164021
  5. The relationship between IL-18 and atherosclerotic cardiovascular risk in Egyptian lean women with polycystic ovary syndrome vol.34, pp.4, 2013, https://doi.org/10.1080/09513590.2017.1395835
  6. Relation between Inflammation, Oxidative Stress, and Macronutrient Intakes in Normal and Excessive Body Weight Adolescent Girls with Clinical Features of Polycystic Ovary Syndrome vol.13, pp.3, 2013, https://doi.org/10.3390/nu13030896